Patent · US Active

Bioluminogenic assay system for measuring beta-lactamase activity

US7867758B2 · kind B2 · utility

0Cited by
6References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2008
Grant dateJan 11, 2011
Priority date
Expiry dateJul 2, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/986
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A bioluminogenic assay system including: providing a bioluminogenic substrate incorporating a beta-lactam antibiotic, a bioluminescence initiating compound, and a chemical linkage joining the beta-lactam antibiotic to the bioluminescence initiating compound; exposing the bioluminogenic substrate to a beta-lactamase enzyme that catalyzes the release of the bioluminescence initiating compound from the bioluminogenic substrate; co-exposing the bioluminogenic substrate to a bioluminescence indicator reaction that employs the bioluminescence initiating compound as a substrate; and detecting a light from the bioluminescence indicator reaction as a measure of the activity of the beta-lactamase enzyme.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.